QB3 Seminar: Serge Saxonov, 10X Genomics. "Building Technologies to Resolve Biology"

Serge Saxonov is co-founder and CEO of 10X Genomics. The Pleasanton-based company is only six years old but has already launched multiple breakthrough products revolutionizing many fields of biology. It has ushered in the age of single cell genomics, achieved over $100M in annual revenue and raised $243M in venture funding. Join us to hear what Serge has learned as leader during this explosive period.

Where & When

Room N-114, Genentech Hall, UCSF Mission Bay (600 16th St., San Francisco)
Noon to 1:00 PM, Thursday, February 21

About the Speaker


Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. He defined vision and strategy, contributed to core inventions, and led the company through multiple phases of rapid growth. In 2016, he was honored as one of Goldman Sachs 100 Most Intriguing Entrepreneurs of the Year. Prior to 10x Genomics, Serge was VP of Applications at QuantaLife, where he was responsible for building content, driving new applications, and identifying key diagnostics opportunities for the core ddPCR technology. Before QuantaLife, Serge was Founding Architect and Director of R&D at 23andMe. There he defined the initial conception of the product, built many elements of the technology, and drove strategy and execution of R&D functions as the company scaled. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics and biology from Harvard College.